ROS has been shown to activate STAT3 (Figures 1, 4) but much later after infection: 4 to 10 days after infection of primary B cells with EBV, ROS activated STAT3 while simultaneously inhibiting viral miRNAs that suppress LMP1 expression. Here, PDLIM7 is linked to infection.